{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:40Z","timestamp":1790334820801,"version":"4.1.0"},"reference-count":78,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Psoriasis is a complex disease with many associated comorbidities, all of which have a negative impact on a patient\u2019s personal, social, and sexual life. There are some unique considerations in the effects of this disease among women. The average age of diagnosis in women with psoriasis is 28 years, and this onset corresponds to the fertile life of women. There is conflicting information about the effects of psoriasis on female fertility. Some studies suggest that this condition\u2019s associated comorbidities, personal behaviors, and reduced ovarian reserve, especially due to chronic inflammation, affect women\u2019s fertility. Another possible reason women with psoriasis are less likely to become pregnant is that their sexual intercourse frequency decreases after the condition\u2019s onset. The available information on the effects of pregnancy on women with psoriasis is limited. According to current evidence, most women will experience an improvement in their skin condition. Studies show that patients with moderate-to-severe psoriasis are more prone to experience pregnancy complications. The management of pregnant and lactating women with psoriasis is also difficult, as the safety profile of commonly used drugs in patients with psoriasis is not entirely known.<\/jats:p>","DOI":"10.3390\/medicina58060780","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T22:37:20Z","timestamp":1655073440000},"page":"780","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Oversight and Management of Women with Psoriasis in Childbearing Age"],"prefix":"10.3390","volume":"58","author":[{"given":"\u0218tefana","family":"Bucur","sequence":"first","affiliation":[{"name":"Department of Family Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5964-7699","authenticated-orcid":false,"given":"Alexandra-Petru\u021ba","family":"Savu","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-9470","authenticated-orcid":false,"given":"Ana Maria Alexandra","family":"St\u0103nescu","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-614X","authenticated-orcid":false,"given":"Elena-Daniela","family":"\u0218erban","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-464X","authenticated-orcid":false,"given":"Alin-Codru\u021b","family":"Nicolescu","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Roma Medical Center for Diagnosis and Treatment, 011773 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5075-9758","authenticated-orcid":false,"given":"Traian","family":"Constantin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Urology, \u201cProf. Dr. Theodor Burghele\u201d Hospital, 050659 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-7354","authenticated-orcid":false,"given":"Anca","family":"Bobirc\u0103","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Internal Medicine and Rheumatology, \u201cDr. I. Cantacuzino\u201d Hospital, 073206 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-3236","authenticated-orcid":false,"given":"Maria-Magdalena","family":"Constantin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Singh, S., Young, P., and Armstrong, A.W. (2017). An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181039"},{"key":"ref_3","first-page":"1291","article-title":"Evaluation and management of psoriasis: An internist\u2019s guide","volume":"93","author":"Levine","year":"2009","journal-title":"Med. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: The diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.120237","article-title":"Metabolic syndrome in patients with psoriatic disease","volume":"89","author":"Gelfand","year":"2012","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13555-021-00662-1","article-title":"Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis","volume":"12","author":"Nowowiejska","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_7","first-page":"e9708","article-title":"Association between Psoriasis and Depression: A Traditional Review","volume":"12","author":"Sahi","year":"2020","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.47102\/annals-acadmedsg.V47N12p516","article-title":"Psychological Profile of Patients with Psoriasis","volume":"47","author":"Lim","year":"2018","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000090652","article-title":"An Italian study on psoriasis and depression","volume":"212","author":"Esposito","year":"2006","journal-title":"Dermatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/09513590.2018.1563884","article-title":"Evaluation of ovarian reserve in women with psoriasis","volume":"35","author":"Bilici","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tjog.2018.02.010","article-title":"Diminished ovarian reserve in patients with psoriasis","volume":"57","author":"Alhan","year":"2018","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_13","first-page":"305","article-title":"Moderate-to-severe psoriasis and pregnancy: Impact on fertility, pregnancy outcome and treatment perspectives","volume":"154","author":"Caldarola","year":"2019","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.sder.2010.01.002","article-title":"Comorbidities in psoriasis patients","volume":"29","author":"Kim","year":"2010","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/humrep\/13.6.1532","article-title":"Smoking and female infertility: A systematic review and meta-analysis","volume":"13","author":"Augood","year":"1998","journal-title":"Hum. Reprod."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2133.2011.10249.x","article-title":"Quality of life and sexual health in patients with genital psoriasis","volume":"164","author":"Meeuwis","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2015.02.1127","article-title":"Genital psoriasis is associated with significant impairment in quality of life and sexual functioning","volume":"72","author":"Ryan","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The immunopathogenesis of psoriasis","volume":"33","author":"Kim","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4362.1996.tb01632.x","article-title":"Psoriasis and pregnancy: Hormone and immune system interaction","volume":"35","author":"Boyd","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/0300-1652.107549","article-title":"Hormones in pregnancy","volume":"53","author":"Kumar","year":"2012","journal-title":"Niger. Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijwd.2015.03.001","article-title":"The immunologic effects of estrogen on psoriasis: A comprehensive review","volume":"1","author":"Danesh","year":"2015","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1995-7645(13)60131-5","article-title":"Effects of estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood during pregnancy","volume":"6","author":"Xiong","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal Effect on Psoriasis in Pregnancy and Post Partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_25","first-page":"183","article-title":"Pregnancy outcome in women with psoriasis","volume":"53","author":"Sheiner","year":"2008","journal-title":"J. Reprod. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1468-3083.2010.03917.x","article-title":"Pregnancy outcomes in women with moderate-to-severe psoriasis","volume":"25","author":"Nachum","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2010.02.005","article-title":"Psoriasis and pregnancy outcomes: A nationwide population-based study","volume":"64","author":"Yang","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden","volume":"98","author":"Haerskjold","year":"2018","journal-title":"Acta Derm.-Venereol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2133.2010.09899.x","article-title":"Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis","volume":"163","author":"Bandoli","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Av\u015far, T.S., McLeod, H., and Jackson, L. (2021). Health outcomes of smoking during pregnancy and the postpartum period: An umbrella review. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-021-03729-1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","first-page":"643","article-title":"Topical corticosteroid use during pregnancy","volume":"58","author":"Alabdulrazzaq","year":"2012","journal-title":"Can. Fam. Physician"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamadermatol.2013.5768","article-title":"Pregnancy Outcomes after Maternal Exposure to Topical Corticosteroids: A UK Population-Based Cohort Study","volume":"149","author":"Chi","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","first-page":"180","article-title":"The effect of narrowband ultraviolet B phototherapy on serum folate level","volume":"12","author":"Hosseini","year":"2021","journal-title":"Caspian J. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1177\/15648265080292S114","article-title":"Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development","volume":"29","author":"Molloy","year":"2008","journal-title":"Food Nutr. Bull."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/IJWH.S125784","article-title":"Pustular psoriasis of pregnancy: Current perspectives","volume":"10","author":"Trivedi","year":"2018","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes","volume":"43","author":"Bandoli","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","journal-title":"Drug Saf."},{"key":"ref_40","unstructured":"Post, T.W. (2022). Management of psoriasis in pregnancy. UpToDate, UpToDate. Available online: https:\/\/www.uptodate.com\/contents\/management-of-psoriasis-in-pregnancy."},{"key":"ref_41","first-page":"599","article-title":"Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester","volume":"99","author":"Nguyen","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.39202.518484.80","article-title":"Management of psoriasis in pregnancy","volume":"334","author":"Weatherhead","year":"2007","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000246811","article-title":"Teratogenic risk with etretinate and acitretin treatment","volume":"189","author":"Geiger","year":"1994","journal-title":"Dermatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"286-e24","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clindermatol.2016.02.013","article-title":"Drug safety: Pregnancy rating classifications and controversies","volume":"34","author":"Wilmer","year":"2016","journal-title":"Clin. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7326\/L17-0629","article-title":"Prolonged Persistence of Adalimumab Transferred from Mother to Infant During Pregnancy","volume":"169","author":"Labetoulle","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cgh.2012.11.030","article-title":"Anti-tumor necrosis factor agents and placental transfer: Relevant clinical data for rational decision-making","volume":"11","author":"Kane","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","article-title":"BSRBR Control Centre Consortium, BSR Biologics Register. Anti-TNF therapies and pregnancy: Outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register","volume":"70","author":"Verstappen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_50","first-page":"1014","article-title":"Tumor necrosis factor-alpha inhibition and VATER association: A causal relationship","volume":"33","author":"Carter","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jri.2016.04.284","article-title":"Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer","volume":"116","author":"Porter","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: Results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: Results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/art.40508","article-title":"Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results from a Pharmacovigilance Safety Database","volume":"70","author":"Clowse","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_56","first-page":"1240","article-title":"Treatment of severe psoriasis with ustekinumab during pregnancy","volume":"11","author":"Andrulonis","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajd.12214","article-title":"Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester","volume":"55","author":"Sheeran","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000380880","article-title":"Pregnancy during Ustekinumab Treatment for Severe Psoriasis","volume":"231","author":"Rocha","year":"2015","journal-title":"Dermatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jdv.12872","article-title":"Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis","volume":"30","author":"Alsenaid","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_60","first-page":"e191","article-title":"Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn\u2019s disease and paradoxical psoriasis","volume":"30","author":"Mook","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3315\/jdcr.2012.1116","article-title":"Spontaneous abortion during ustekinumab therapy","volume":"6","author":"Fotiadou","year":"2012","journal-title":"J. Dermatol. Case Rep."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Venturin, C., Nancey, S., Danion, P., Uzzan, M., Chauvenet, M., Bergoin, C., Roblin, X., Flouri\u00e9, B., and Boschetti, G. (2017). Fetal death in utero and miscarriage in a patient with Crohn\u2019s disease under therapy with ustekinumab: Case-report and review of the literature. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0633-6"},{"key":"ref_63","unstructured":"European Medicines Agency (2022, February 19). Taltz: Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/taltz-epar-product-information_en.pdf."},{"key":"ref_64","unstructured":"European Medicines Agency (2022, February 19). Cosentyx: Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cosentyx-epar-product-information_en.pdf."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/bjd.16901","article-title":"Secukinumab in pregnancy: Outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database","volume":"179","author":"Warren","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_66","unstructured":"Golbari, N.M., Basehore, B.M., and Zito, P.M. (2021). Brodalumab. StatPearls, StatPearls Publishing."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.2147\/DDDT.S167149","article-title":"Risankizumab: An anti-IL-23 antibody for the treatment of psoriasis","volume":"12","author":"Haugh","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_68","unstructured":"European Medicines Agency (2022, February 19). Skyrizi: Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/skyrizi-epar-product-information_en.pdf."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/ecco-jcc\/jjab093","article-title":"Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn\u2019s Disease: Results from the Phase 2 Open-Label Extension Study","volume":"15","author":"Ferrante","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5114\/ada.2020.102089","article-title":"The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: A review of current clinical guidelines","volume":"37","author":"Owczarek","year":"2020","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/dth.12071","article-title":"Dermatoses of the breast in lactation","volume":"26","author":"Barrett","year":"2013","journal-title":"Dermatol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ad.2020.10.002","article-title":"Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement. Consenso sobre las actuaciones a seguir durante la edad f\u00e9rtil, el embarazo, el posparto y la lactancia en pacientes con psoriasis","volume":"112","author":"Velasco","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2013.09.009","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation","volume":"70","author":"Butler","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_74","first-page":"185","article-title":"Factitious hypertension with mineralocorticoid excess in an infant","volume":"38","author":"Bongo","year":"1983","journal-title":"Helv. Paediatr. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Simionescu, A.A., Danciu, B.M., and Stanescu, A.M.A. (2021). State-of-the-Art Review of Pregnancy-Related Psoriasis. Medicina, 57.","DOI":"10.3390\/medicina57080804"},{"key":"ref_76","first-page":"487","article-title":"Acitretin excretion into human breast milk","volume":"70","author":"Rollman","year":"1990","journal-title":"Acta Derm. Venereol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0002-9378(72)90824-1","article-title":"Secretion of methotrexate into human milk","volume":"112","author":"Johns","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_78","unstructured":"(2022, February 21). Drugs and Lactation Database (LactMed), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501653."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/6\/780\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:26:53Z","timestamp":1760138813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/6\/780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":78,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["medicina58060780"],"URL":"https:\/\/doi.org\/10.3390\/medicina58060780","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}